Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocular conditions

Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocular conditions

US Patent 11395853 · Granted Jul 26, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Controlled release formulations for the induction and proliferation of blood cel2025
Polymer-based implant for retinal therapy and methods of making and using the sa2025
Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocul2025
Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocul2025
Vasoactive intestinal peptide release from microparticles2025
Vasoactive intestinal peptide release from microparticles2025
Thermoresponsive hydrogel containing polymer microparticles for controlled drug 2025
Gel for treating periocular and/or orbital pathologies and conditions2025
Autoimmune disease treatment with chemokine-loaded alginate microparticles2024
Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocula2024
Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocula2024
Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocula2024